WO1989009049A1 - Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration - Google Patents

Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration Download PDF

Info

Publication number
WO1989009049A1
WO1989009049A1 PCT/US1989/001400 US8901400W WO8909049A1 WO 1989009049 A1 WO1989009049 A1 WO 1989009049A1 US 8901400 W US8901400 W US 8901400W WO 8909049 A1 WO8909049 A1 WO 8909049A1
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
injectable
per day
magnetized
times per
Prior art date
Application number
PCT/US1989/001400
Other languages
French (fr)
Inventor
Walter Whitson Fischman
Original Assignee
Walter Whitson Fischman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter Whitson Fischman filed Critical Walter Whitson Fischman
Priority to IN258/CAL/89A priority Critical patent/IN169075B/en
Publication of WO1989009049A1 publication Critical patent/WO1989009049A1/en
Priority to IN1043/CAL/90A priority patent/IN171749B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Definitions

  • This invention relates to homeopathic medicament? and methods for the treatment of illness and injury in human being ⁇ u ⁇ ir ⁇ such homeopathic medicaments.
  • the invention relates to homeopathic methods of treatment of conditions including illnesses, pathogenic diseases, allergies, chemical and hormonal imbalances, addictive chemical dependencies, and physical injuries to the human body.
  • the methods of treatment include oral, topical, auricular and injectable forms of homeopathic formulations which are magnetically treated or influenced during administeration to a patient through specific acupuncture points.
  • Homeopathy is an ancient healing art and forms a vital part of medical therapy.
  • the practice of homeopathy is widespread, particularly in eastern cultures and many European countries.
  • Homeopathic medicine teaches the use cf natural based remedies and, as such, provides an alternative to traditional allopathic medicine which relies heavily on the use of petrochemical based pharmaceuticals.
  • Homeopathic remedies use pharmaceutical preparations based on the use of herbs or herbal extracts.
  • Homeoparhic remedies function in a totally different manner than chemical-based pharmaceuticals in that _ ⁇ _ they do not require administering high concentration? of active ingredient to produce the desired results.
  • Traditional allopathic pharmaceuticals can be thought of as working quantitatively, that is, the results achieved are generally proportional to the potency and frequency of the dosage administered.
  • homeopathic pharmaceuticals can be thought of as working- qualitatively in that even the minutest quantities of their active ingredients produce a therapeutic effect by inducing natural body mechanisms to return to their proper level of activity characteristic of a healthful or uninjured state.
  • Homeopathic remedies function by inducing natural body mechanisms and processes to return to their optimum healthful level of operation; that is, their natural biological "set points". Through our modern understanding of genetics each bodily member and process is seen as the result of codes programmed into each individual cell.
  • Homeopathic medicine seeks to utilize natural substances, particularly herbs, to naturally and gently induce the body to restore its equilibri- um, that is, for all function and processes to return to their set points.
  • Homeopathic medicine looks upon illness and disease as being a state of disequilibrium from the body's optional set points.
  • a fundamental precept of homeopathic medicine is that a small force or stimulating agent can produce disproportionally greater results, if optimally and effectively applied.
  • homeopathic medicaments are relatively inexpensive as compared to traditional chemical-based pharmaceuticals.
  • Another fundamental precept in the formulation of homeopathic pharmaceuticals is that repetitive dilution from an original concentrate does not diminish efficacy of the formulation.
  • Acupuncture involves the relief of symptoms and the cure of illness and injury by the controlled stimulation of points on the human body which regulate or interact with the functioning of specific organs or bodily members to which the acupuncture points are related.
  • the pain cycle can be broken and the natural healing process induced.
  • Stimulation through acupunc- ture which typically involves the insertion of small needles into the acupuncture points on the body, causes a release of endorphins which block pain sensed over the neurological pathways and enable other natural healing mechanisms in the body to restore a condition of homeopathic equilibrium to the body by killing invasive pathogens, restoring chemical or hormonal imbalance . or fostering the mending of physically injured tissues, muscles and/or bones.
  • specific points on the human body have been determined which regulate the functioning of all bodily members and processes.
  • the appropriate points for stimulation for any given condition are known to skilled practitioners in the art.
  • One particular acupuncture treatment system developed in Japan by Dr. Yo ⁇ hic Manaka is based on a conception of the human body as encompassing two basic systems, an energetic system and an informational system.
  • the energetic system utilizes the greater portion of energy in the body.
  • the informational system controls the energetic system and responds to both external and internal stimuli.
  • Acupuncture is viewed, as a therapeutic modality which interacts with and regulates the body's informational system.
  • the human body's susceptibility to magnetic fields is due in large part to the electrolytic properties of many of the chemical constituents of the body. All electrolytic substances are capable of conducting an electric current and wherever an electric current is flowing, a magnetic field is created. The greater the electrolytic properties of the substance, the greater is its conductivity and therefore the greater the resulting magnetic field created during current flow.
  • the body generates a magnetic field of its own due " partly to the presence of iron ⁇ carrying charged particles flowing in the blood stream.
  • Other electrolytic substances in the body such as potassium and sodium, in ionic form, are present in substantial amounts and contribute to the body's overall bioelectric/biomagnetic field.
  • blood cells are readily polarized when placed in a magnetic field due to the high iron concentration in the blood. Under certain conditions, magnetic fields alter the orientation of blood cells and induce changes in the biological reactions in which they participate, thereby modifying the probability of chemical bond formation.
  • Human blood is very slightly alkaline with respect to body cells which are more acidic. Magnetic fields can be used to induce reactions which restore the pH of the blood.
  • Therapeutic magnetic energy fields also produce a stimulating component which in the case of traumatic physical injury dilates blood vessels and increases blood circulation, disperses fluid build-up due to inflammation, and strengthens and promotes the healing of damaged tissue.
  • pulsed magnetic energy has been observed to cause transcutaneous electrical neural stimulation and contributes to the reduction of chronic pain by causing the release of natural pain relieving substances at the spinal cord level and by causing the release of endorphins and ACTH at the pituitary gland level.
  • a primary object of the present in ⁇ vention is to disclose a new modality of medical therapy which utilizes aspects of homeopathic pharmaceutical therapy, acupuncture therapy and biomagnetic therapy, in combination.
  • a further object of the invention is to devise a full range of modes of administration of magnetically induced homeopathic remedies, including topical, injectable, auricular and oral forms.
  • a further object of the invention is to provide particular homeopathic pharmaceutical formulations for the treatment of specific illnesses, physical injuries and other chemical and hormonal disequilibrium conditions of the human body with precisely determined acupuncture sites to which the homeopathic pharmaceutical remedies are to be applied in the treatment of each specific condition.
  • a further object of the invention is to provide appropriate means for inducing the biomagnetic field in the homeopathic pharmaceutical remedy for each form of adminis ⁇ tration.
  • the present invention is directed to a method of treatment of human illness and injury by administering to the patient homeopathic medicaments through selected acupuncture points stimulated by a controlled magnetic field.
  • a very " broad spectrum of human illnesses can be effectively treated by homeopathic medicaments of the instant invention through selection of the appropriate homeopathic remedy, preparation of a mixture of the homeopathic remedy and a magnetically permeable component and magnetization of the resulting mixture, during administration to the patient through specific acupuncture sites.
  • Various embodiments of the invention include administering therapeutic amounts of the magnetic mixture in oral, injectable, topical and auricular forms. Further, depending upon the condition being treated the dosage and frequency of administration will vary. In a particularly preferred embodiment the patient is administered with a regimen of both oral and injectable dosages.
  • Figures 1A and IE show two preferred embodiments of oral delivery vehicles for the administration of homeopathic medicaments
  • Figures 2A and 2B show embodiments for the topical administration of a homeopathic medicament
  • Figure 3 shows a preferred embodiment for imparting a magnetic field to the injectable form homeopathic medicaments
  • the homeopathic medicaments of the present invention when administered through specific acupuncture sites have demonstrated remarkable efficacy in the treatment of a wide range of afflictions, many of which have no known cure in the realm of allopathic medicine.
  • Effective delivery systems for these homeopathic formulations have been devised including topical, injectable, auricular and oral forms.
  • the homeopathic medicament administered in whatever form is selected, must first be carefully mixed with an. effective amount of a magnetically permeable ingredient.
  • a magnetically permeable ingredient such as sodium sulfate, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium sulfate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium
  • One delivery system used is by injection.
  • the formulation dosage and duration of treatment for the injectible medicaments is described in detail in the formulation examples which follow. Since it has been observed that injecting homeopathic medicaments demonstrate unexpected and significantly enhanced efficacy when a unipolar magnetic charge is imparted to the medicament during administration or injection into an acupuncture point, a device has been developed to enable the administering physician to suitably charge the medicament.
  • One such device is shown in Figure 3. This device consists of a housing 10 containing an electromagnetic coil 12 positioned to impart a controlled magnetic charge to plate 14.
  • a syringe or hypodermic needle 16 used to inject the homeopathic medicament can be positioned in housing 10 such that the point of the needle or syringe is in close proximity to plate 14 as shown in Figure 3.
  • Topical Another alternative delivery system used is the topical.
  • the topical patch 20 is made cf a porous material such a ⁇ sintered metal capable of absorbing a therapeutic amount of homeopathic medicament.
  • the patch 20 has an extended opening therethrough in which is tightly fitted a metal rod or core 22 which can readily accept and retain a magnetic charge. Suitable materials include iron and nickel.
  • the patch 20 can then be impregnated with a therapeutic amount of desired homeopathic medicament.
  • a unipolar magnetic charge is then imparted to the metallic core 22 of patch 20 which is then affixed to a suitable acupuncture point.
  • One method for affixing the topical patch to the acupuncture point is to hold it in place with adhesive bandage, surgical tape or the like.
  • the magnetically influenced homeopathic medicament can be placed in a band which can be comfortably strapped around the member at the desired location.
  • the homeopathic pharmaceutical formulation can be magnetized _in situ by placing a permanent magnet or ether source of magnetic flux on top of the portion of the homeopathic mixture to be agnet- ically activated.
  • FIG. 2B Still another form of a topical for administering homeopathic medicaments is a pellet or "button" as illustrated in Figure 2B.
  • the button 30 can be stamped out under pressure in a process generally known as the sintered metal process.
  • a 50/50 powdered mixture of Ni (nickel) and Fe (iron) is fed into a press mold. This composition inhibits corrosion and readily accepts and holds a magnetic charge. Since the finished pellet or button is porous it can easily be impregnated like a sponge with a therapeutic homeopathic tincture.
  • the button is then formed with pressure to the desired shape.
  • buttons 30 effectively increases the overall therapeutic effect cf the topical by providing direct physical stimulation of the acupuncture point.
  • the smooth domed top of button 30 is desirable as being less obtrusive on the surface cf the skin.
  • the button 30 is formed and impregnated with medicament, it is magnetically charge so that the desired polarity is imparted to the under surface cf the button which is affixed in place over a pre-selected acupuncture point.
  • One polarity is on the upper surface of the button (the domed surface away from the 1 _ skin) and the other pole is on the lower surface of the button in contact with the skin.
  • Still another form of administering homeopathic medicaments is orally by means of a pill or tablet. Two such oral tablets are shown in Figures 1A and IB.
  • this oral device can aptly be described as a medicinal "lollipop" consisting of a rod portion 40 and a ball or bulbous portion 42.
  • the rod 40 is made up of a metal such as iron capable of holding a magnetic charge.
  • the ball portion 42 has an inert core such as molded plastic, for example.
  • the rod 40 is coated with a plastic or vinyl coating 44 extending to the ball portion 42.
  • the ball portion 42 is coated with a homeopathic composition made of sugar and Ferrous gluconate mixed to a dilution in the range of 3x to 4x. It is then impregnated with an alcohol tincture containing the desired homeopathic medicament.
  • the entire device can be encased in a sanitary wrapping.
  • the entire device in its wrapping if desired is first placed in a suitable electromagnetic field.
  • all of the metallic elements of the device are magnetized with the ball portion being charged with one polarity and the rod portion with the opposite polarity.
  • the therapeutic portion of the device having a unipolar charge can then be placed under the tongue of the patient in order to contact the acupuncture points in the mouth.
  • a pill as shown in Figure IB can be used.
  • the pill 50 has a core 52 formed of a standard homeopathic sugar globule made in conventional manner.
  • Dry Ferrous gluconate powder (USP grade) is triturated with very fine sugar in a 1-9 proportion in a grinding machine to make a homeopathic dilution of 2X.
  • a second dilution (designed as 3X) is made in the same 1-9 proportions using the 2X dilution and additional sugar. Succeeding dry dilutions are made in the same manner to a final dilution of 5X.
  • the 5X dilution of the Ferrous gluconate and sugar is used to build inner layer 54 which surrounds the core 52.
  • Layer 54 is built up by tu bling in a coating pan in accordance with known methods for the manufacture of homeopathic remedies. Layer 54 is then covered with a coating 56 which is impermeable to water and alcohol. Ferrous gluconate is added to coating 56 so that it will have the same magnetic permeability as layer 54 containing ferrous gluconate and sugar. An outer layer 58 is then built up around coating 56 in the same manner as inner layer 54 was formed. The thickness of outer layer 58 should be approximately twice that of inner layer 5? for optimum results and is similarly made of a Ferrous gluconate sugar mixture in 5X dilution. The pills are then thoroughly air dried. The diameter of the finished pill should preferably be approximately one centimeter.
  • the layered pill made a.ccording to this procedure can then be medicated in conventional manner.
  • a measured weight of the finished, dried pills is placed in a suitable container and a predetermined amount of the desired homeopathic medicinal tincture is added.
  • the homeopathic tincture is of a dilution of 3OX which has been manufactured ir. accordance with traditional homeopathic procedure from herbs or other raw materials.
  • the containers with the pills are then rotated in a roller mill for approximately one hour to permit the pills to completely absorb the alcohol tincture.
  • the pills are then transferred from the containers to paper covered trays where they are air drie ⁇ until no trace or odor of the alcohol remains.
  • the pills are then individually packaged (a single pill to each container) in a vial-like tube with a threaded cap or tightly fitting friction lid.
  • the cap is preferably larger in diameter than the vial so that it projects to form a rim around the vial at the top. Pre ⁇ cautions should be taken during processing to avoid contamina ⁇ tion or de-activation of th -pills.
  • the medicated pills can then be administered to the patient.
  • a vial containing the pills is placed into a ⁇ uit- able magnetic filed so that each piil is magnetized just pricr to inge ⁇ tion by the patient.
  • the pill should be inserted directly into the mouth from the vial without handling.
  • the patient can then suck on the pill to gradually dissolve it until the impermeable coating is reached at which point the patient should discard the remainder of the pill.
  • Yet another form of administering the homeopathic medicaments is by auricular measures.
  • One such device consists of an earplug containing dosages of the homeopathic medicament which can be administered through holes in the earplug to the acupuncture points in the ear.
  • the earplug device can be made by any number of means with the understanding that it must be able to uncontrollably release medicament to predetermined auricular acupuncture points. This can best be accomplished by either using rods or small protrusions aligned with the acupuncture points and capable of releasing medicament.
  • the homeopathic medicament is magnetized after it is deposited in the earplug device in accordance with the procedure described above for imparting a magnetic charge to the topical or oral forms of administration.
  • An injectable dosage form of an herb-based homeopathic medicament designated FNG-11, for the treatment of fungus and yeast infections, having a homeopathic potency of SOX was prepared from an original concentrated tincture menstrum containing extracts cf the herbs Tecoma conspicua and
  • Example 2 Melaleuca alternifolia in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed depending upon the number of acupuncture points being used. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 2
  • the original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline.
  • Ferrous gluconate a magnetically permeable substance in a homeopathic potency of 4 X (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field.
  • Injectable dosage portions of 0.2cc volumes were set aside as needed.
  • the formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
  • An injectable dosage form of an herb-based homeopathic medicament designated VR-27, for the treatment of broad spectrum viral infections, having a homeopathic potency of SOX was prepared from an original concentrated tincture menstruum containing an extract of the herb Centella asiatica minor in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency cf 4 x (10-4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions cf 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 4
  • the original concentrated tincture was then diluted to 30X potency (10 ⁇ " times the original concentration) with sterile isotonic saline.
  • Ferrous gluconate a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed.
  • An injectable dosage form of an herb-based homeopathic medicament for the treatment of hypothyroidism, was prepared from an original concentrated tincture menstruum containing an extract of the herb Organ protomcrpho im in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 -4-) , was added to the dilute homeopathic solution in order for it to hol a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
  • An injectable dosage form of an herb-based homeopathic medicament for the treatment of premenstrual syndrome, menopause, and reproductive hormonal imbalance, was prepared from an original concentrated tincture menstruum containing an extract of the herb Angelica sinensis in 99+% alcohol.
  • the original concentrated tincture was then diluted to 30X potency (10 times the original concentration) with sterile isotonic saline.
  • Ferrous gluconate a magnetically permeable substance in a homeopathic potency of 4 x 10 ) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field.
  • Injectable dosage portions of 0.2cc volumes were set aside as needed.
  • Example 7 An injectable dosage form of a homeopathic medicament, designated HYT-12, for the treatment of hydro- thyroidism, was prepared from an original concentrated tincture menstruum containing a solution of aqueous iodine in
  • the original concentrated tincture was diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline.
  • Ferrous gluconate a magnetically permeable substance in. a homeopathic potency of 4 x f!0 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field.
  • Injectable dosage portions of 0.2cc volumes were set aside as needed.
  • the formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
  • Example 8 An injectable dosage form of an herb-based homeopathic medicament for the treatment of hypertension, designated RLX-22, was prepared from an original tincture menstruu containing extracts of the herbs Rock Pose, Clematis, Impatien ⁇ , Cherry Plum, and Star of Bethlehem in
  • An injectable dosage form of an herb-based homeopathic medicament, designated IMM-2, for restoring and strengthening the body's natural immune system, having a homeopathic potency of 30X was prepared from an original concentrated tincture menstruum containing extracts of the herbs Astragalus membranaceous, Nux vomica, Panix ginseng, Germanium and extract of Thymus gland in 99+% alcohol. The original concentrated tincture was then diluted to 3OX potency (10 -30 times the original concentration) with sterile isotonic saline.
  • Ferrous gluconate a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field.
  • Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
  • An injectable cc ⁇ are form of a homeopathic medicament for the treatment of hypoglycemia designated HYG-6, was prepared from an original concentrated tincture menstruum containing sulfur and glycerin in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the ori ⁇ inal concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge w en passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed.
  • Example 11 An injectable dosage form of an herb-based homeopathic medicament, designated INF-16, for the treatment of bacterial infections, particularly staff and strep, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Senecia scandens, Scutellaria baicalensis, Magnolia officinalis, Lonicera japonica, and
  • Andrographis paniculata in 99+% alcohol was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline.
  • Ferrous gluconate a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field.
  • Injectable dosage portions cf 0.2cc volumes were set aside as needed.
  • An injectable dosage form of an herb-based homeopathic medicament, designated FLU-17, for the treatment of viral infections due to colds and influenza, particularly rhino-virus, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Lonicera confusa. Chrysanthemum indicum, Vitex negundo, Eucdia epta, Ilex asprella, Menthol, and Baphicacan hu ⁇ cu ⁇ ia in 99+% alcohci. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline.
  • Ferrous gluconate a magnetically — A permeable substance in a homeopathic potency of 4 x (10 * ) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
  • Ferrous gluconate a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized at the time of administration through the acupuncture sites as described above.
  • Example 14
  • An injectable dosage form of an herb-based homeopathic medicament for the treatment of chronic muscular and joint pain, was prepared from an original ccncentrated tincture menstruuiri containing an extract of the herb Rhus toxicodendron in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency cf 4 (10 -4) , was added to the dilute homeopathic solution in order for it to hold ⁇ magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 15
  • SMK-30 An injectable dosage form of ⁇ homeopathic medicament, designated SMK-30, for the treatment of nicotine addiction and the craving to smoke cigarettes, other nicotine containing tobacco products, and the like, having a homeopathic potency cf 3OX was prepared from an original
  • An oral dosage form of the herb-based homeopathic medicament FNG-11, prepared as set forth in Example 1 above, 25 having a homeopathic potency of 3OX was prepared in accordance with the procedure described above in connection with the pill illustrated in Figure IB.
  • Example 20 An oral dosage form of the herb-based homeopathic medicament SPN-7 , as in Example 4, having a homeopathic potency cf SOX, was prepared according to the method of Example 16.
  • Example 20 An oral dosage form of the herb-based homeopathic medicament SPN-7 , as in Example 4, having a homeopathic potency cf SOX, was prepared according to the method of Example 16.
  • Example 21 An oral dosage form of the homeopathic medicament TYR-10, as in Example 5, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
  • Example 21 An oral dosage form of the homeopathic medicament TYR-10, as in Example 5, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
  • Example 22 An oral dosage form of the herb-based homeopathic medicament HRM-4, as in Example 6, having a homeopathic pctency of 30X, was prepared according to the method of Example 16.
  • Example 22 An oral dosage form of the herb-based homeopathic medicament HRM-4, as in Example 6, having a homeopathic pctency of 30X, was prepared according to the method of Example 16.
  • Example 23 An oral dosage form of the herb-based homeopathic medicament RLX-22, as in Example 8, having a homeopathic pctency cf 30X, was prepared according to the method of Example 16.
  • Example 24 An oral dosage form cf the herb-based homeopathic medicament IMM-2, as in Example 9, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
  • Example 25 An oral dosage form cf the herb-based homeopathic medicament HYG-6, as in Example 10, having a homeopathic potency of 3OX, was prepared according to the method cf Example 16.
  • Example 26 An oral dosage form cf the herb-based homeopathic medicament I1F-16, as in Example 11, havir. ⁇ ⁇ homeopathic potency of 30X, was prepared according to the method of Example 16.
  • Example 27 An oral dosage form cf the herb-based homeopathic medicament I1F-16, as in Example 11, havir. ⁇ ⁇ homeopathic potency of 30X, was prepared according to the method of Example 16.
  • Example 28 An oral dosage form of the herb-based homeopathic medicament GLG-17, as in Example 12, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
  • Example 28
  • Example 29 An oral dosage form of the herb-based homeopathic medicament ALL-5, as in Example 13, having a homeopathic potency of SOX, was prepared according to the method of Example 16.
  • Example 29 An oral dosage form of the herb-based homeopathic medicament ALL-5, as in Example 13, having a homeopathic potency of SOX, was prepared according to the method of Example 16.
  • Example 30 An oral dosage form of the herb-based homeopathic medicament OPN-26, as in Example 14, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
  • Example 30
  • Example 16 where the original concentrated tincture menstruum contained extracts of the herb Coryandru ⁇ ⁇ ativa.
  • Example 31 A combined treatment regimen utilizing both the injectable and oral dosage forms of the FNG-11 homeopathic medicament (prepared according to Examples 1 and 16, respectively) , was used in the treatment of a 44 year old female patient. Prior to treatment the patient exhibited symptoms including mood swings, premenstrual syndrome (P. .S.), and fatigue, and was diagnosed as a result of visible yeast in a live cell analysis as suffering from candidiasis.
  • the injectable form dosage of FNG-11 was administered two times per week during the first week and once per-week thereafter bilaterally to the two SP-6 acupuncture points. Duration of treatment by the injectable mode was for a total period of four weeks.
  • Oral dosage forms were admini ⁇ tered at an initial dosage rate of 3 tablets taken 5 times per day during the first week of treatment, reduced to 3 times per day during the second week of treatment and finally to 2 times per day for the balance of the duration of the treatment.
  • the total duration of treatment under the oral form was for a period of 4 weeks.
  • the patient's blood level yeast decreased by 60%.
  • the patient's P.M.S. and other symptoms were controlled.
  • Example 32 A combined treatment regimen utilizing both the injectable and oral dosage forms of the VR-27 homeopathic medicament (prepared according to Examples 3 and 18, respectively) , was used in the treatment of a 41 year old male exhibiting symptoms including a histcry cf prostatiti ⁇ and gonorrhea with active leiscn ⁇ approximately 60-70% of the time. The patient was diagnosed as being infected with herpes simplex 2.
  • the injectable form dosage of the VR-27 was administered two times per week during the first week and once per week thereafter bilaterally to the two Tk-5 acupuncture points and the oral form dosage was administered initially at a rate of 3 tablets taken 5 times per day during the first week of treatment, reduced to 3 times per day during the second week of treatment and finally to 2 times per day for the balance of the duration of the treatment. Both the injectable and oral form dosages were administered for a total treatment period of 6 weeks. After 3 weeks of treatment, the patient 8 s condition improved to the extent that there were no active lesions and no further outbreaks of genital herpes.
  • Example 33 A combined treatment regimen of oral and injectable forms of VR-27 was utilized in the treatment of a 33 year old female of slender build and good muscle structure.
  • the patient exhibited classic symptoms of Chronic Epstein-Barr Virus including chronic fatigue, unrefreshed sleep, dark circles under the eyes, headaches, burning eyes, hypersensitivity to bright lights and smoke, non-specific muscle aches in shifting locales, lack of coordination, lack of balance, and persistent bouts of depressions that sometimes reached profound levels. She was uncertain of exact dates but felt that she had had most of these symptoms for several years.
  • VGA E-B Virus antibody virus titer
  • the patient was treated on a weekly basis with the homeopathic medicament by taking 3 oral tables t.i.d.
  • the injectable form of VR-27 was injected through the TW-5 acu- puncture point.
  • Treatment continued for a period of approxi ⁇ mately 2 months.
  • the follow-up blood work shewed that the same anti-body titer had fallen to a level of 1:320; well below the critical point and within the range considered normal.
  • the clinical signs and symptoms confirmed the lab work and the patient reported virtual freedom from the previous physical and emotional problems. She continued to be free of symptoms 18 months later.

Abstract

A method for treating pathogenic conditions of the human body by preparing a mixture of at least one herb, herbal extract or other compound exhibiting therapeutic properties, adding a magnetically permeable substance to the mixture, magnetizing the resulting mixture to impart a substantially unipolar magnetic charge on the mixture and administering the magnetized mixture through one or more specific acupuncture points associated with producing a desired response to the particular condition being treated. The invention is also directed to the treatment of various diseases through the oral, auricular, topical or injectable administration of homeopathic medicaments.

Description

MAGNETICALLYINFLUENCEDHOMEOPATHICPHARMACEUTICALFORMULATIONS METHODSOFTHEIRPREPARATIONANDMETHODSOFTHEIRADMINISTRATION.
FIELD OF THE INVENTION
This invention relates to homeopathic medicament? and methods for the treatment of illness and injury in human beingε uεirσ such homeopathic medicaments.
More particularly, the invention relates to homeopathic methods of treatment of conditions including illnesses, pathogenic diseases, allergies, chemical and hormonal imbalances, addictive chemical dependencies, and physical injuries to the human body. The methods of treatment include oral, topical, auricular and injectable forms of homeopathic formulations which are magnetically treated or influenced during administeration to a patient through specific acupuncture points.
BACKGROUND OF THE INVENTION Homeopathy is an ancient healing art and forms a vital part of medical therapy. The practice of homeopathy is widespread, particularly in eastern cultures and many European countries. Homeopathic medicine teaches the use cf natural based remedies and, as such, provides an alternative to traditional allopathic medicine which relies heavily on the use of petrochemical based pharmaceuticals. There has been a large increase in interest in homeopathic medicine in the
United States in recent years due, in large part, to a growing disenchantment with allopathic medications and the complications and side effects arising from their use.
Frequently, the administration of allopathic medications results in serious side effects more deleterious to the patient than the basic condition being treated. Today, more and more individuals are looking for a gentler, safer path to good health free of the risks and side effects associated with traditional allopathic medicine. Furthermore, such medicines are often prohibitively expensive, particularly for patients who are indigent or elderly.
Homeopathic remedies, on the other hand, use pharmaceutical preparations based on the use of herbs or herbal extracts. Homeoparhic remedies function in a totally different manner than chemical-based pharmaceuticals in that _τ_ they do not require administering high concentration? of active ingredient to produce the desired results. Traditional allopathic pharmaceuticals can be thought of as working quantitatively, that is, the results achieved are generally proportional to the potency and frequency of the dosage administered. By comparison, homeopathic pharmaceuticals can be thought of as working- qualitatively in that even the minutest quantities of their active ingredients produce a therapeutic effect by inducing natural body mechanisms to return to their proper level of activity characteristic of a healthful or uninjured state. Homeopathic remedies function by inducing natural body mechanisms and processes to return to their optimum healthful level of operation; that is, their natural biological "set points". Through our modern understanding of genetics each bodily member and process is seen as the result of codes programmed into each individual cell. Homeopathic medicine seeks to utilize natural substances, particularly herbs, to naturally and gently induce the body to restore its equilibri- um, that is, for all function and processes to return to their set points. Homeopathic medicine looks upon illness and disease as being a state of disequilibrium from the body's optional set points. A fundamental precept of homeopathic medicine is that a small force or stimulating agent can produce disproportionally greater results, if optimally and effectively applied. Thus, proper administra¬ tion of a small quantity of a homeopathic medicine can have a large effect in restoring the body to its proper state of equilibrium. A further advantage of homeopathic medicaments is that they are relatively inexpensive as compared to traditional chemical-based pharmaceuticals. Another fundamental precept in the formulation of homeopathic pharmaceuticals is that repetitive dilution from an original concentrate does not diminish efficacy of the formulation.
Thus, large quantities of homeopathic pharmaceuticals can be prepared from a relatively small amount of starting solution. Further, the starting ingredients themselves are natural and relatively inexpensive. The formulation of solutions of homeopathic pharmaceuticals is also a relatively simple process. In contrast, the manufacture of traditional chemi¬ cal-based pharmaceuticals generally involves a complicated and costly chemical manufacturing process. Moreover, because the effectiveness of such traditional chemical-based pharmaceuti¬ cals resides in the potency of the formulation administered, dilution of the pharmaceutical to a lower potency results in reduced e ectiveness. Generally, all such chemical-based pharmaceuticals must be formulated at or near the concen¬ tration level or potency at which they will ultimately be administered. Thus, in order to produce large quantities of a pharmaceutical , proportionately large manuf cturing facilities are required, which only further adds to the expenεiveness of the chemical-based pharmaceuticals utilized in classical allopathic medicine.
Another ancient and long accepted healing art is acupuncture which is believed to have originated in the
Orient. Acupuncture involves the relief of symptoms and the cure of illness and injury by the controlled stimulation of points on the human body which regulate or interact with the functioning of specific organs or bodily members to which the acupuncture points are related.
Modern science has tried to determine the mechanism by which acupuncture works. One proposed explanation is that stimulation of acupuncture points on the body causes the release of endorphinε by the body. Endorphins are natural substances released within the body which, among other functions, operate to desensitize neurological pathways by which pain is perceived. By relieving the pain associated with symptoms and with illness and injury, the body itself is then able to utilize its natural immune system and the healing process to restore equilibrium and a normal healthful condi¬ tion. Natural set points are restored and the affliction thereby eliminated. Pain acts as a warning indicator that -A- so ething is wrong in the body. By determining the source of the pain and the acupuncture points on the body to which the pain is responsive, the pain cycle can be broken and the natural healing process induced. Stimulation through acupunc- ture, which typically involves the insertion of small needles into the acupuncture points on the body, causes a release of endorphins which block pain sensed over the neurological pathways and enable other natural healing mechanisms in the body to restore a condition of homeopathic equilibrium to the body by killing invasive pathogens, restoring chemical or hormonal imbalance . or fostering the mending of physically injured tissues, muscles and/or bones. Over the many years that acupuncture has been practiced, specific points on the human body have been determined which regulate the functioning of all bodily members and processes. Thus, the appropriate points for stimulation for any given condition are known to skilled practitioners in the art.
One particular acupuncture treatment system developed in Japan by Dr. Yoεhic Manaka is based on a conception of the human body as encompassing two basic systems, an energetic system and an informational system. The energetic system utilizes the greater portion of energy in the body. The informational system controls the energetic system and responds to both external and internal stimuli. Acupuncture is viewed, as a therapeutic modality which interacts with and regulates the body's informational system. By influencing the informational system, large changes can be induced with minimal stimulation while allowing the body to function as naturally as possible while its processes are gradually restored to their equilibrium set points.
A recent development in methods of medical treatment has been the discovery of the therapeutic properties of magnetic and electro-magnetic fields and their use in the treatment of illness and injury. Modern science has demonstrated that all living beings exhibit an electro¬ magnetic field about them. Homeopathic medicine teaches that illness and injury create disturbances to the body's natural electro- agnetic fields. The administration of therapeutic fields restores the body's natural fields to their equilibriu levels. The therapeutic effects of the application of pulsed magnetic fields in the treatment of traumatic injuries to limbs, muscles, tendons, bones and the like, as well as in the treatment of illness such as arthritis, is well-known in the art of medical science.
The human body's susceptibility to magnetic fields is due in large part to the electrolytic properties of many of the chemical constituents of the body. All electrolytic substances are capable of conducting an electric current and wherever an electric current is flowing, a magnetic field is created. The greater the electrolytic properties of the substance, the greater is its conductivity and therefore the greater the resulting magnetic field created during current flow.
The body generates a magnetic field of its own due " partly to the presence of iron^carrying charged particles flowing in the blood stream. Other electrolytic substances in the body such as potassium and sodium, in ionic form, are present in substantial amounts and contribute to the body's overall bioelectric/biomagnetic field. It is well known that blood cells are readily polarized when placed in a magnetic field due to the high iron concentration in the blood. Under certain conditions, magnetic fields alter the orientation of blood cells and induce changes in the biological reactions in which they participate, thereby modifying the probability of chemical bond formation.
Human blood is very slightly alkaline with respect to body cells which are more acidic. Magnetic fields can be used to induce reactions which restore the pH of the blood.
For example, in a condition prompted by over-acidity of the blood, that is, one characterized by a low pH, applica¬ tion of magnetic field energy emanating from the north pole of a magnet, which, by convention, is considered to be negative, and which, homeopathically, iε considered to be alkaline, helps to restore the blood to its normal pH level. It has also been shown that the blood's leucocyte count is influenced by magnetic fields. The number of leucocytes in the blood increases or decreases depending on prevailing magnetic field conditions. Therapeutic treatments utilizing magnetic energy operate to produce two curative effects. Therapeutic magnetic fields produce a treatment component which in the case of traumatic physical injury causes a reduction in swelling, a reduction of edema, a draining of fluid build-up due to inflammation and a desensitization to pain.
Therapeutic magnetic energy fields also produce a stimulating component which in the case of traumatic physical injury dilates blood vessels and increases blood circulation, disperses fluid build-up due to inflammation, and strengthens and promotes the healing of damaged tissue.
The application of pulsed magnetic energy has been observed to cause transcutaneous electrical neural stimulation and contributes to the reduction of chronic pain by causing the release of natural pain relieving substances at the spinal cord level and by causing the release of endorphins and ACTH at the pituitary gland level.
As a result of research into the fields of homeopathic pharmaceutical medicine, acupuncture and biomagnetic therapy, a new modality of medical treatment has been developed which combines the features of all three of the above treatment methods in a noval way. Accordingly, a new and unique method of medical treatment has been discovered which is more efficacious than any of the three methods described above. OBJECTS OF THE INVENTION
Accordingly, a primary object of the present in¬ vention is to disclose a new modality of medical therapy which utilizes aspects of homeopathic pharmaceutical therapy, acupuncture therapy and biomagnetic therapy, in combination. A further object of the invention is to devise a full range of modes of administration of magnetically induced homeopathic remedies, including topical, injectable, auricular and oral forms.
A further object of the invention is to provide particular homeopathic pharmaceutical formulations for the treatment of specific illnesses, physical injuries and other chemical and hormonal disequilibrium conditions of the human body with precisely determined acupuncture sites to which the homeopathic pharmaceutical remedies are to be applied in the treatment of each specific condition. A further object of the invention is to provide appropriate means for inducing the biomagnetic field in the homeopathic pharmaceutical remedy for each form of adminis¬ tration.
SUMMARY OF THE INVENTION The present invention is directed to a method of treatment of human illness and injury by administering to the patient homeopathic medicaments through selected acupuncture points stimulated by a controlled magnetic field. A very " broad spectrum of human illnesses can be effectively treated by homeopathic medicaments of the instant invention through selection of the appropriate homeopathic remedy, preparation of a mixture of the homeopathic remedy and a magnetically permeable component and magnetization of the resulting mixture, during administration to the patient through specific acupuncture sites.
Various embodiments of the invention include administering therapeutic amounts of the magnetic mixture in oral, injectable, topical and auricular forms. Further, depending upon the condition being treated the dosage and frequency of administration will vary. In a particularly preferred embodiment the patient is administered with a regimen of both oral and injectable dosages.
BRIEF DESCRIPTION OF THE DRAWINGS Aspects cf the present invention are illustrated by the accompanying drawings in which: Figures 1A and IE show two preferred embodiments of oral delivery vehicles for the administration of homeopathic medicaments;
Figures 2A and 2B show embodiments for the topical administration of a homeopathic medicament;
Figure 3 shows a preferred embodiment for imparting a magnetic field to the injectable form homeopathic medicaments; and
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION
The homeopathic medicaments of the present invention when administered through specific acupuncture sites have demonstrated remarkable efficacy in the treatment of a wide range of afflictions, many of which have no known cure in the realm of allopathic medicine. Effective delivery systems for these homeopathic formulations have been devised including topical, injectable, auricular and oral forms.
In accordance with the teaching of the present invention the homeopathic medicament, administered in whatever form is selected, must first be carefully mixed with an. effective amount of a magnetically permeable ingredient. Although numerous compounds are suitable, it'has been found that ferrous gluconate is particularly effective. The resulting mixture is then prepared for administration to the patient depending upon the specific delivery system used. During administration to the patient, the medicament is charged or influenced by a magnetic field which imparts a unipolar charge to the medicament as it enters the body through a pre-selected acupuncture point. Such application of a magnetic charge at or in close proximity to the acupuncture site is believed to stimulate or activate the acupuncture site thereby enhancing the therapeutic efficacy of the medicament being administered.
Particularly effective results have been achieved when applying relatively small levels of magnetic charge in the range of 1 to 10 gauss to the medicament as it is being administered through the acupuncture point. Such low levels oi magnetic flux can aptly be described as homeopathic. It has further been found that the most effective acupuncture sites are located in the arms and legs below the eibcw and knee, respectively. These points are commonly referred to ?ε the "command points" and are well known to those skilled ir the art.
Having described the invention in its most fundamental terms, the various forms of administration of medicament will now be described in detail. Reference is made to the accompanying figures where appropriate.
One delivery system used is by injection. The formulation dosage and duration of treatment for the injectible medicaments is described in detail in the formulation examples which follow. Since it has been observed that injecting homeopathic medicaments demonstrate unexpected and significantly enhanced efficacy when a unipolar magnetic charge is imparted to the medicament during administration or injection into an acupuncture point, a device has been developed to enable the administering physician to suitably charge the medicament. One such device is shown in Figure 3. This device consists of a housing 10 containing an electromagnetic coil 12 positioned to impart a controlled magnetic charge to plate 14. A syringe or hypodermic needle 16 used to inject the homeopathic medicament can be positioned in housing 10 such that the point of the needle or syringe is in close proximity to plate 14 as shown in Figure 3.
Another alternative delivery system used is the topical. One particularly preferred topical is illustrated in Figure 2A. The topical patch 20 is made cf a porous material such aε sintered metal capable of absorbing a therapeutic amount of homeopathic medicament. The patch 20 has an extended opening therethrough in which is tightly fitted a metal rod or core 22 which can readily accept and retain a magnetic charge. Suitable materials include iron and nickel. The patch 20 can then be impregnated with a therapeutic amount of desired homeopathic medicament. A unipolar magnetic charge is then imparted to the metallic core 22 of patch 20 which is then affixed to a suitable acupuncture point.
One method for affixing the topical patch to the acupuncture point is to hold it in place with adhesive bandage, surgical tape or the like. For preparations that are to be affixed to acupuncture points cn the limbs, such as on the wrists, arms, ankles or legs, the magnetically influenced homeopathic medicament can be placed in a band which can be comfortably strapped around the member at the desired location.
In certain alternative embodiments, the homeopathic pharmaceutical formulation can be magnetized _in situ by placing a permanent magnet or ether source of magnetic flux on top of the portion of the homeopathic mixture to be agnet- ically activated.
Still another form of a topical for administering homeopathic medicaments is a pellet or "button" as illustrated in Figure 2B. The button 30 can be stamped out under pressure in a process generally known as the sintered metal process. To fabricate the button, a 50/50 powdered mixture of Ni (nickel) and Fe (iron) is fed into a press mold. This composition inhibits corrosion and readily accepts and holds a magnetic charge. Since the finished pellet or button is porous it can easily be impregnated like a sponge with a therapeutic homeopathic tincture. The button is then formed with pressure to the desired shape.
A protrusion 32 on the underside of button 30 effectively increases the overall therapeutic effect cf the topical by providing direct physical stimulation of the acupuncture point. Although other shapes can certainly be used, the smooth domed top of button 30 is desirable as being less obtrusive on the surface cf the skin. After the button 30 is formed and impregnated with medicament, it is magnetically charge so that the desired polarity is imparted to the under surface cf the button which is affixed in place over a pre-selected acupuncture point. One polarity is on the upper surface of the button (the domed surface away from the 1 _ skin) and the other pole is on the lower surface of the button in contact with the skin.
Still another form of administering homeopathic medicaments is orally by means of a pill or tablet. Two such oral tablets are shown in Figures 1A and IB.
With reference to Figure 1A, this oral device can aptly be described as a medicinal "lollipop" consisting of a rod portion 40 and a ball or bulbous portion 42. The rod 40 is made up of a metal such as iron capable of holding a magnetic charge. The ball portion 42 has an inert core such as molded plastic, for example. The rod 40 is coated with a plastic or vinyl coating 44 extending to the ball portion 42. The ball portion 42 is coated with a homeopathic composition made of sugar and Ferrous gluconate mixed to a dilution in the range of 3x to 4x. It is then impregnated with an alcohol tincture containing the desired homeopathic medicament.
The entire device can be encased in a sanitary wrapping. To use the "lollipop" the entire device in its wrapping if desired is first placed in a suitable electromagnetic field. In this way, all of the metallic elements of the device are magnetized with the ball portion being charged with one polarity and the rod portion with the opposite polarity. In this manner, the therapeutic portion of the device having a unipolar charge can then be placed under the tongue of the patient in order to contact the acupuncture points in the mouth.
Alternativly, a pill as shown in Figure IB can be used. The pill 50 has a core 52 formed of a standard homeopathic sugar globule made in conventional manner. Dry Ferrous gluconate powder (USP grade) is triturated with very fine sugar in a 1-9 proportion in a grinding machine to make a homeopathic dilution of 2X. A second dilution (designed as 3X) is made in the same 1-9 proportions using the 2X dilution and additional sugar. Succeeding dry dilutions are made in the same manner to a final dilution of 5X. The 5X dilution of the Ferrous gluconate and sugar is used to build inner layer 54 which surrounds the core 52.' Layer 54 is built up by tu bling in a coating pan in accordance with known methods for the manufacture of homeopathic remedies. Layer 54 is then covered with a coating 56 which is impermeable to water and alcohol. Ferrous gluconate is added to coating 56 so that it will have the same magnetic permeability as layer 54 containing ferrous gluconate and sugar. An outer layer 58 is then built up around coating 56 in the same manner as inner layer 54 was formed. The thickness of outer layer 58 should be approximately twice that of inner layer 5? for optimum results and is similarly made of a Ferrous gluconate sugar mixture in 5X dilution. The pills are then thoroughly air dried. The diameter of the finished pill should preferably be approximately one centimeter.
The layered pill made a.ccording to this procedure can then be medicated in conventional manner. For example, a measured weight of the finished, dried pills is placed in a suitable container and a predetermined amount of the desired homeopathic medicinal tincture is added. The homeopathic tincture is of a dilution of 3OX which has been manufactured ir. accordance with traditional homeopathic procedure from herbs or other raw materials. The containers with the pills are then rotated in a roller mill for approximately one hour to permit the pills to completely absorb the alcohol tincture. The pills are then transferred from the containers to paper covered trays where they are air drieα until no trace or odor of the alcohol remains. The pills are then individually packaged (a single pill to each container) in a vial-like tube with a threaded cap or tightly fitting friction lid. The cap is preferably larger in diameter than the vial so that it projects to form a rim around the vial at the top. Pre¬ cautions should be taken during processing to avoid contamina¬ tion or de-activation of th -pills.
The medicated pills can then be administered to the patient. A vial containing the pills is placed into a εuit- able magnetic filed so that each piil is magnetized just pricr to ingeεtion by the patient. The pill should be inserted directly into the mouth from the vial without handling. The patient can then suck on the pill to gradually dissolve it until the impermeable coating is reached at which point the patient should discard the remainder of the pill.
Yet another form of administering the homeopathic medicaments is by auricular measures. One such device consists of an earplug containing dosages of the homeopathic medicament which can be administered through holes in the earplug to the acupuncture points in the ear. The earplug device can be made by any number of means with the understanding that it must be able to uncontrollably release medicament to predetermined auricular acupuncture points. This can best be accomplished by either using rods or small protrusions aligned with the acupuncture points and capable of releasing medicament. For best results, the homeopathic medicament is magnetized after it is deposited in the earplug device in accordance with the procedure described above for imparting a magnetic charge to the topical or oral forms of administration.
The following examples illustrate the embodiments of various aspects of the invention. The examples are provided to illustrate the scope of the invention and are not intended - to be limiting. Other applications of aspects of the in¬ vention within its broad scope will be apparent to those skilled in the art. FORMULATION EXAMPLES A. INJECTABLE
Example 1
An injectable dosage form of an herb-based homeopathic medicament designated FNG-11, for the treatment of fungus and yeast infections, having a homeopathic potency of SOX was prepared from an original concentrated tincture menstrum containing extracts cf the herbs Tecoma conspicua and
Melaleuca alternifolia in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed depending upon the number of acupuncture points being used. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 2
An injectable dosage form of an herb-based homeopathic medicament, designated HG-9, for the treatment of intestinal parasites, particularly Giardia lamblia and Entamoeba histolytica, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Osbeckia chinensiε, Pulsatilla chinensis, Punica granatum, Acalpha australis, Cephaelis ipecacuanha, Picrasma ailanthoides, Asarum sieboldi, Brucea javanica. Magnolia officinalis, Artemysia apiacea, and Dichroa febrifuga in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 X (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 3
An injectable dosage form of an herb-based homeopathic medicament designated VR-27, for the treatment of broad spectrum viral infections, having a homeopathic potency of SOX was prepared from an original concentrated tincture menstruum containing an extract of the herb Centella asiatica minor in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency cf 4 x (10-4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions cf 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 4
An injectable dosage form of an herb-based homeopathic medicament, designated SPN-7, for the treatment of traumatic injury to muscles, tendons, ligaments, and for the treatment of sprains, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Radix pεeudoginseng, Dryobalanops aromatica, Cynura segetu , and Moschns moεchiferous in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10~" times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed.
The formulations injected weae controllably magnetized during administration through the acupuncture sites as described above. Example 5
An injectable dosage form of an herb-based homeopathic medicament, designated TYR-10, for the treatment of hypothyroidism, was prepared from an original concentrated tincture menstruum containing an extract of the herb Organ protomcrpho im in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 -4-) , was added to the dilute homeopathic solution in order for it to hol a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 6
An injectable dosage form of an herb-based homeopathic medicament, designated HRM-4, for the treatment of premenstrual syndrome, menopause, and reproductive hormonal imbalance, was prepared from an original concentrated tincture menstruum containing an extract of the herb Angelica sinensis in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x 10 ) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 7 An injectable dosage form of a homeopathic medicament, designated HYT-12, for the treatment of hydro- thyroidism, was prepared from an original concentrated tincture menstruum containing a solution of aqueous iodine in
99+% alcohol. The original concentrated tincture was diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in. a homeopathic potency of 4 x f!0 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 8 An injectable dosage form of an herb-based homeopathic medicament for the treatment of hypertension, designated RLX-22, was prepared from an original tincture menstruu containing extracts of the herbs Rock Pose, Clematis, Impatienε, Cherry Plum, and Star of Bethlehem in
99+% alcohol. The oriσinal concentrated tincture was then diluted to 30X potency (10 -30 times the original concen- tration) v/ith sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4
- A x (10 ') , was added to the dilute homeopathic solutio in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 9
An injectable dosage form of an herb-based homeopathic medicament, designated IMM-2, for restoring and strengthening the body's natural immune system, having a homeopathic potency of 30X was prepared from an original concentrated tincture menstruum containing extracts of the herbs Astragalus membranaceous, Nux vomica, Panix ginseng, Germanium and extract of Thymus gland in 99+% alcohol. The original concentrated tincture was then diluted to 3OX potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.
Example 10
An injectable ccεare form of a homeopathic medicament for the treatment of hypoglycemia, designated HYG-6, was prepared from an original concentrated tincture menstruum containing sulfur and glycerin in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the oriσinal concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge w en passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 11 An injectable dosage form of an herb-based homeopathic medicament, designated INF-16, for the treatment of bacterial infections, particularly staff and strep, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Senecia scandens, Scutellaria baicalensis, Magnolia officinalis, Lonicera japonica, and
Andrographis paniculata in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions cf 0.2cc volumes were set aside as needed.
The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 12
An injectable dosage form of an herb-based homeopathic medicament, designated FLU-17, for the treatment of viral infections due to colds and influenza, particularly rhino-virus, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Lonicera confusa. Chrysanthemum indicum, Vitex negundo, Eucdia epta, Ilex asprella, Menthol, and Baphicacan huε cuεia in 99+% alcohci. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically — A permeable substance in a homeopathic potency of 4 x (10 * ) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 13
An injectable dosage form of an herb-based homeopathic medicament, designated ALL-5, for the treatment of hayfever and airborne allergies, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Gentiana luta. Citrus aurantium, Tanacetum vulgare, Chicuε benedictus, Menyanthes trifoliata, Grindelia robusta, and Ephedra sinica in 99+% alcohol. The original concentrated tincture was then diluted to 3OX potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 -4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized at the time of administration through the acupuncture sites as described above. Example 14
An injectable dosage form of an herb-based homeopathic medicament, designated OPN-26, for the treatment of chronic muscular and joint pain, was prepared from an original ccncentrated tincture menstruuiri containing an extract of the herb Rhus toxicodendron in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency cf 4 (10 -4) , was added to the dilute homeopathic solution in order for it to hold α magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above. Example 15
5 An injectable dosage form of α homeopathic medicament, designated SMK-30, for the treatment of nicotine addiction and the craving to smoke cigarettes, other nicotine containing tobacco products, and the like, having a homeopathic potency cf 3OX was prepared from an original
10 concentrated tincture menstruum containing an extract of cigarette smoke in 99+% alcohol. The original concentrated tincture was then diluted to 30X potency (10 -30 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic
1 -i5c- potency of 4 x (10-4) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the 20 acupuncture sites as described above.
B. ORAL FORM
Example 16
An oral dosage form of the herb-based homeopathic medicament FNG-11, prepared as set forth in Example 1 above, 25 having a homeopathic potency of 3OX was prepared in accordance with the procedure described above in connection with the pill illustrated in Figure IB.
Example 17
An oral dosage form of the herb-based homeopathic 30 medicament HG-9, as in Example 2, having a homeopathic potency of 30X, was prepared according to the method of Example 16.
Example 18
An oral dosage form of the herb-based homeopathic medicament VR-27, as in Example 3, having a homeopathic 35 potency of 3OX, was prepared according to the method of
Example 16. Example 19
An oral dosage form of the herb-based homeopathic medicament SPN-7 , as in Example 4, having a homeopathic potency cf SOX, was prepared according to the method of Example 16. Example 20
An oral dosage form of the homeopathic medicament TYR-10, as in Example 5, having a homeopathic potency of 30X, was prepared according to the method of Example 16. Example 21
An oral dosage form of the herb-based homeopathic medicament HRM-4, as in Example 6, having a homeopathic pctency of 30X, was prepared according to the method of Example 16. Example 22
An oral dosage form of the homeopathic medicament TYR-12, as in Example 7, having a homeopathic potency of 30X, was prepared according to the method of Example 16. Example 23 An oral dosage form of the herb-based homeopathic medicament RLX-22, as in Example 8, having a homeopathic pctency cf 30X, was prepared according to the method of Example 16. Example 24 An oral dosage form cf the herb-based homeopathic medicament IMM-2, as in Example 9, having a homeopathic potency of 30X, was prepared according to the method of Example 16. Example 25 An oral dosage form cf the herb-based homeopathic medicament HYG-6, as in Example 10, having a homeopathic potency of 3OX, was prepared according to the method cf Example 16. Example 26 An oral dosage form cf the herb-based homeopathic medicament I1F-16, as in Example 11, havir.σ ε homeopathic potency of 30X, was prepared according to the method of Example 16. Example 27
An oral dosage form of the herb-based homeopathic medicament GLG-17, as in Example 12, having a homeopathic potency of 30X, was prepared according to the method of Example 16. Example 28
An oral dosage form of the herb-based homeopathic medicament ALL-5, as in Example 13, having a homeopathic potency of SOX, was prepared according to the method of Example 16. Example 29
An oral dosage form of the herb-based homeopathic medicament OPN-26, as in Example 14, having a homeopathic potency of 30X, was prepared according to the method of Example 16. Example 30
An oral dosage form of an herb-based homeopathic medicament, designated GU-14, for the treatment of gastric discomfort, borborygmi, and flatus, having a homeopathic potency of 30X, was prepared according to the method of
Example 16, where the original concentrated tincture menstruum contained extracts of the herb Coryandruε εativa.
Clinical Examples Example 31 A combined treatment regimen utilizing both the injectable and oral dosage forms of the FNG-11 homeopathic medicament (prepared according to Examples 1 and 16, respectively) , was used in the treatment of a 44 year old female patient. Prior to treatment the patient exhibited symptoms including mood swings, premenstrual syndrome (P. .S.), and fatigue, and was diagnosed as a result of visible yeast in a live cell analysis as suffering from candidiasis. The injectable form dosage of FNG-11 was administered two times per week during the first week and once per-week thereafter bilaterally to the two SP-6 acupuncture points. Duration of treatment by the injectable mode was for a total period of four weeks. Oral dosage forms were adminiεtered at an initial dosage rate of 3 tablets taken 5 times per day during the first week of treatment, reduced to 3 times per day during the second week of treatment and finally to 2 times per day for the balance of the duration of the treatment. The total duration of treatment under the oral form was for a period of 4 weeks. As a result of the above treatments, the patient's blood level yeast decreased by 60%. The patient's P.M.S. and other symptoms were controlled. Example 32 A combined treatment regimen utilizing both the injectable and oral dosage forms of the VR-27 homeopathic medicament (prepared according to Examples 3 and 18, respectively) , was used in the treatment of a 41 year old male exhibiting symptoms including a histcry cf prostatitiε and gonorrhea with active leiscnε approximately 60-70% of the time. The patient was diagnosed as being infected with herpes simplex 2. The injectable form dosage of the VR-27 was administered two times per week during the first week and once per week thereafter bilaterally to the two Tk-5 acupuncture points and the oral form dosage was administered initially at a rate of 3 tablets taken 5 times per day during the first week of treatment, reduced to 3 times per day during the second week of treatment and finally to 2 times per day for the balance of the duration of the treatment. Both the injectable and oral form dosages were administered for a total treatment period of 6 weeks. After 3 weeks of treatment, the patient8s condition improved to the extent that there were no active lesions and no further outbreaks of genital herpes. Example 33 A combined treatment regimen of oral and injectable forms of VR-27 was utilized in the treatment of a 33 year old female of slender build and good muscle structure. The patient exhibited classic symptoms of Chronic Epstein-Barr Virus including chronic fatigue, unrefreshed sleep, dark circles under the eyes, headaches, burning eyes, hypersensitivity to bright lights and smoke, non-specific muscle aches in shifting locales, lack of coordination, lack of balance, and persistent bouts of depressions that sometimes reached profound levels. She was uncertain of exact dates but felt that she had had most of these symptoms for several years.
A blood test verified the diagnosis of Epstein-Barr Virus. The E-B Virus antibody virus titer (VGA) was positive at 1:5120.
The patient was treated on a weekly basis with the homeopathic medicament by taking 3 oral tables t.i.d. The injectable form of VR-27 was injected through the TW-5 acu- puncture point. Treatment continued for a period of approxi¬ mately 2 months. At the end of this time the follow-up blood work shewed that the same anti-body titer had fallen to a level of 1:320; well below the critical point and within the range considered normal. The clinical signs and symptoms confirmed the lab work and the patient reported virtual freedom from the previous physical and emotional problems. She continued to be free of symptoms 18 months later. Example 34
A female patient 36 years old, who was slightly overweight exhibited symptoms of constant vaginal infections with associated burning, itching and discharge. She com¬ plained of extremely low energy level and felt that she was in a state of unremitting depressions, Frequent attacks of acute diarrhea after food intake were accompanied by headaches and nausea. She feels much of her weight problem is water re¬ tention (abdominal bloating) and reports a large number of various food allergies. Relatively the same roster of com¬ plaints have been present in various combination for a period that, she estimates, could be as long as twelve years. The patient diagnosed as suffering from chronic Candida albicans. Initial laboratory tests disclosed the following levels: IgG - 136 (normal max 100) IgA - 214 (normal max 100) IgM - 143 (normal max 100) The patient was treated with FNG-11 in injectable form in¬ troduced into acupuncture point SP-6 on a once a week basis in addition to oral tablets of the same medication for 8 weeks. Following treatment laboratory tests disclosed the following levels:
IgG - 51
IgA - 96 lgM - 99 The patient also reported a total cessation of the initiating and chronic symptoms complained of and has been fully comfort¬ able with no recurrence since.

Claims

WHAT IS CLAIMED IS:
1. A method for treating pathogenic conditions of the human body comprising the steps of: preparing a mixture of at least one herb, herbal extract or other compound having therapeutic properties to which a particular condition being treated is responsive; adding a magnetically permeable substance to the mixture; magnetizing the resulting mixture in a magnetic field to impart a substantially unipolar magnetic charge on said mixture; and administering the magnetized mixture through one or more specific acupuncture points of the body which are associated with producing a desired- response to the particular condition being treated.
2. The method of claim 1 wherein the mixture is magnetized in a magnetic field of less than ten gauss.
3. The method of claim 1 wherein the magnetized mixture is topically administered to the body.
4. The method of claim 1 wherein the magnetized mixture is injectably administered to the body.
5.. The method of claim 1 wherein the magnetized mixture is auricularly administered to the body.
6. The method of claim 1 wherein the magnetized mixture is orally administered to the body.
7. The method of claim 3 wherein a therapeutic amount of the magnetized mixture is placed over at least one of said acupuncture points on the surface of the body.
8. The method of claim 4 wherein a therapeutic amount of the magnetized mixture is injected into at least one of said acupuncture points of the body.
9. The method of claim 5 wherein a therapeutic amount of the magnetized mixture is placed in receptacles in a device for insertion into the auricular eatus, the receptacles being locate in said device such that the magnetized mixture is in contact with at least one auricular acupuncture point when the device is inserted in the auricular meatus.
10. The method of claim 6 wherein a therapeutic amount of the magnetized mixture, formed into a pill having an inert sugar-based core surrounded by a first layer comprised oi a mixture of sugar and magnetically permeable compound and said firεt layer is coated with a magnetically permeable layer which is impermeable to water and alcohol and said coating is surrounded by a second layer substantially the same compositionε as the tirst layer and approximately twice the diameter, is placed in the mouth upon being controllably magnetized and the patient sucks on the pill until the second layer is dissolved and the impermeable coating is reached after which the pill is discarded.
11. The method of claim 6 wherein a therapeutic amount of the magnetized mixture is administered tc acupuncture points in the mouth by means of an oral delivery device which is magnetically transparent and permeable comprising a rod portion connected to a ball wherein said rod portion "having a core capable of accepting and holding a magnetic charge and covered by a plastic or vinyl coating extending to the ball portion which is impregnated with an effective amount of said mixture, wherein said ball portion of the device is magnetized to one polarity and the patient then places the ball portion of the device under the tongue to activate the acupuncture points.
12. The method of claim 7 wherein the mixture of at least one therapeutic herb and a magnetically permeable substance is magnetized by placing a source of magnetic flux in proximity tc the mixture while it is placed over one or more acupuncture points cn the surface of the body.
13. A method for the treatment of conditions of the human body including injuries, illnesses, pathogenic diseases, allergies and chemical and hormonal imbalances, the method comprising the administration of a combination of oral and injectable forms of a therapeutic amount of a magnetized solution containing a solute cf one or more therapeutic herbs or herbal extracts or other compounds having properties to which the particular condition being treated, is responsive, the solute being dissolved in a solvent, where the solvent for the oral form is a mixture of 99+% alcohol, and the solvent for the injectεible foria is a mixture of 99+% alcohol diluted with sterile isotonic saline, together with a magnetically permeable, non-toxic substance; and wherein the oral form is impregnated into a solid placed in the mouth to release the magnetized mixture contained therein thereby stimulating acupuncture points in the mouth? and where the injectable form is injected at specific acupuncture points of the body related to the part of the body or the condition being treated; the oral and injectable treatments being administered in appropriate dosages for a sufficient period of time depending on the severity of the condition and the response of the patient being treated, with provision for a further period of maintenance treatments of different dosage and frequency of administration where symptoms of the condition persist.
14β The method of claim 11 wherein the condition being treated is traumatic injury to one or more joints, muscles, tendons and ligaments and the solute of the magnetized solution comprises an effective amount of one or more herbs or herbal extracts selected from the group consisting of Radix pseudoginseng, Dryobaianops aromatica, Gynura segetum and Moεchus moschiferous.
15. The method of claim 14 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 3OX, administered to the acupuncture points and related local acupuncture points for the specific injured member being treated, the injections being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is from 1 to 6 weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
16. The method of claim 11 wherein the condition being treated is hypothyroidism and the solute of the magnetized solution comprises an extract of thyroid organ protomorphogin.
17. The method of claim 3 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 3OX, administered bilaterally to each of the two LI-11 acupuncture points, the injections being given initially 2 times per week for the firεt week of treatment and once per week on successive weeks over the course cf treatment; and wherein the duration of both the oral and injectable modes of treatment is six weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
18. The method of claim 11 wherein the condition being treated is one or more of pre-menstrual syndrome, menopause and reproductive hormonal imbalance in female human beings and the solute of the magnetized solution comprises the herb Angelica sinensis or an extract thereof.
19. The method of claim 16 wherein the oral dosage is a tablet having a homeopathic potency of 3OX, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 3OX, administered bilaterally to each of the two SP-6 acupuncture points, the injections being given initially from 1 to 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes cf treatment is from 1 to 2 weeks, followed by a period of maintenance of several weeks where the symptoms of the condition persist.
20. The method cf claim 11 wherein the condition being treated is emotional depressions, and hypertension and the solute cf the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Rock Rose, Clematis, Impatienε, Cherry Plum, and Star of Bethlehem.
21. The method of claim 18 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced t-o two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to one pair of the HE-5, HE-6 or HE-7 acupuncture points, administered a total of once or twice; and wherein the duration cf the oral mode of treatment is from 1 to 6 weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
22. The method of claim 11 wherein the condition being treated is a reduction in the body's natural immune system and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Anthemis nobiliε, Smilax officinalis, Angelica officinalis, Medicago sativa, Rhamnus purschiana, Apium graveolenε. Astragalus membranaceous. Taraxacum officinale, Gentiana lutea, Marrubium vulgare, Glycyrrhiza glabra, Pasεiflora incarnata, Serenoa εerrulata, and Polygala senega.
23o The method of claim 20 wherein the oral dosage is a tablet having a homeopathic potency of SOX, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to each pair of the LI-11, SP-6, HE-5, EE-6 and HE-7 acupuncture points, the injection being- given initially 2 times per week for the first week cf treatment and once per week on successive weeks over the course cf treatment; and wherein the duration of both the oral and injectable modes of treatment is 6 weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
24. The method of claim 11 wherein the condition being treated is hypogiycemia and the solute of the magnetized solution comprises a mixture of sulfur and glycerin.
25. The method of claim 22 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of SOX, administered bilaterally to each of the two ST-36 acupuncture points initially 2 times per week for the firεt week of treatment and once per week on successive weeks over the course cf treatment; and wherein the duration of both the oral and injectable modes of treatment is 2 weeks, followed by a period of maintenance of several weeks where the symptoms of the condition persist.
26. The method of claim 11 wherein the condition being treated is a general or localized bacterial infection of the body, and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Senecia scandens, Scutellaria baicalensis, Magnolia officinalis, Lonicera japonica, and Andrographis paniculata.
27. The method of claim 24 wherein the oral dosage is a tablet having a homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to each of the two LI-11 acpuncture points, the injections being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration cf both the oral and injectable modes of treatment is from 2 to 6 weeks, followed by a period of maintenance or several weeks where symptoms of the condition persist.
28. The method of claim 11 wherein the condition being treated is a general virus infection of the body and the solute of the magnetized solution comprises the herb Centella asiatica minor or an extract thereof.
29. The method of claim 26 wherein the oral dosage is a tablet having a homeopathic potency of SOX, administered initially as 2 tablets three times per day, reduced tc two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of from 5X to 3OX, administered bilaterally to each of the two TW-5 acupuncture points, the injections being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is 6 weeks, followed by a period of maintenance of several weeks where the symptoms of the condition persist.
30. The method of claim 11 wherein the condition being treated is a cold caused by the rhino-virus or influenza and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Lonicera confuεa, Chrysanthemum indicum, Vitex negundo, Eucdia lepta. Ilex asprella. Menthol, and Baphicacanthus cusia.
31. The method of claim 28 wherein the oral dosage is a tablet having a homeopathic potency of SOX, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 5X. administered bilaterally to each of the two TW-5 acupuncture points, the injections being given initially 1 or 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes cf treatment is from 1 to 3 weeks, followed by a period of maintenance of several weeks where symptoms cf the condition persist.
32. The method of claim 11 wherein the condition being treated isone or more of hay fever and airborne allergies caused by pollens, spores and the like, and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Gentiana luta, Citrus aurantiu , Tanacetum vulgare, Chicuε benedictus, Menyanthes trifoliata, Grindelia robustα, and Ephedra sinica.
33. The method of claim 30 wherein the oral dosage is a tablet having a homeopathic potency of 5X administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection cf 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to each of the two SP-9 acupuncture points, the injections being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is three weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
34. The method of claim 11 wherein the condition being treated is one or more of local and systemic fungus and yeast infections, and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting cf Teco a conspicua and Melaleuca alternifoliα.
35. The method of claim 32 wherein the oral dosage is a tablet having α homeopathic potency of 30X, administered initially as 2 tablets three times per day, reduced tc two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of from 30X to SOX, administered bilaterally tc each of the two SP-6 acupuncture points, the •injection being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is from 2 to 4 weeks, followed by a period of maintenance of several weeks where the symptoms of the condition persist.
36. The method of claim 11 wherein the condition being treated is infestation with intestinal parasites and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Osbeckia chinenεis, Pulsatilla chinensis, Punica granatum, Acalpha australiε, Cephaelis ipecacuanha, Picrasma ailanthoideε, Asaru sieboldi, Brucea javanica, Magnolia officinalis, Artemisia apiacea, and Dichroa febrifuga.
37. The method of claim 34 wherein the oral dosage is a tablet having a homeopathic potency cf 30X, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, administered bilaterally to both pairs of the ST-36 and ST-37 acupuncture points, the injections being given initially 2 times per week for the first week of treatment and once per week on successive weeks over the course of treatment; and wherein the duration of both the oral and injectable modes of treatment is from 4 to 6 weeks, followed by a period of maintenance of several weeks where symptoms of the condition persist.
38. The method of claim 11 wherein the condition being treated is chronic muscular and joint pain and the solute of the magnetized solution comprises the herb Rhuε tcxicodendron or an extract thereof.
39. The method of claim 36 wherein the oral dosage is a tablet having a homeopathic potency cf SOX, administered initially as 2 tablets three times per day, reduced to two times per day and finally to once per day over the course of treatment; wherein the injectable dosage is an injection cf 0.2 cc per acupuncture poi t cf the injectable solution having a homeopathic potency of 3OX, administered to the trigger acupuncture points relating to the members where pain is experienced and to specific pain points, the injections being given initially 2 times per week for the first week of treatment and once per week on εucceεsive weeks over the ccurεe of treatment; and wherein the duration of both the oral and injectable modes of treatment is from one to six weeks, followed by a period of maintenance of several weeks if required.
40. A method for the treatment of at least one of gastric discomfort, borborygmi and flatus in human beings comprising the administration of an oral form of a therapeutic amount of a magnetized solution containing as a solute the herb Coryandius εativa or an extract thereof and aε a εolvent a mixture of 99+% alcohol, diluted with ethanol, together with a magnetically permeable, non-toxic εubεtance; wherein the oral form is a milk-sugar tablet carrier impregnated v/ith the oral form solution; the tablet having a homeopathic potency of 5X; wherein the tablet is allowed to dissolve in the mouth to coat the acupuncture points in the mucous membrane of the mouth with the solution.
41. The method of claim 38, v/herein 3 tablets are administered as frequently as necesεary until palliative relief of symptoms is experienced.
42. A method for the treatment of nicotine addiction and the craving to smoke cigarettes, other nicotine containing tobacco products, and the like in human beingε,. comprising the administration of an injectable form of a therapeutic amount of a magnetized solution containing aε a εolute cigarette εmoke or an extract thereof and as a solvent a mixture of 99+% alcohol diluted with sterile isotonic saline, together with a magnetically permeable, non-toxic substance; the injectable solution having a homeopathic potency of 3OX, wherein the solution is injected in an amount of 0.2 cc per acupuncture point, bilaterally at two special acupuncture points of the body.
43. The method of claim 42 wherein the injectable magnetized solution is injected on a one-time only basis.
PCT/US1989/001400 1988-04-01 1989-04-03 Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration WO1989009049A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN258/CAL/89A IN169075B (en) 1988-04-01 1989-04-05
IN1043/CAL/90A IN171749B (en) 1988-04-01 1992-12-19

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US176,731 1980-08-11
US17673188A 1988-04-01 1988-04-01

Publications (1)

Publication Number Publication Date
WO1989009049A1 true WO1989009049A1 (en) 1989-10-05

Family

ID=22645606

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1989/001400 WO1989009049A1 (en) 1988-04-01 1989-04-03 Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration

Country Status (7)

Country Link
EP (1) EP0409893A4 (en)
JP (1) JPH03503648A (en)
AU (1) AU632481B2 (en)
CA (1) CA1334936C (en)
IN (1) IN169075B (en)
NZ (1) NZ228593A (en)
WO (1) WO1989009049A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0469661A1 (en) * 1990-08-01 1992-02-05 Enza Ciccolo Method for the indentification of frequency and bioenergetic activities in waters and their use
FR2675385A1 (en) * 1991-04-18 1992-10-23 Boulay Maurice Tranquillising and revitalising product containing powdered magnetite
WO1997001355A1 (en) * 1995-06-26 1997-01-16 Antonio Sacchetti Magnetic or electromagnetically induced energization of natural substances
WO2002066041A1 (en) * 2001-02-23 2002-08-29 Herbal Detox Therapy Aps Natural composition
US6552035B2 (en) * 2001-09-13 2003-04-22 Hwa-Mok Park Composition for inducing smoking cessation comprising alkaloids from Radix ipecauanhae
US6844014B1 (en) 2002-07-22 2005-01-18 Stephen Rafkin Herbal healing lotion for veterinary use
EP3166620A1 (en) * 2014-07-11 2017-05-17 Marianna Gross Homeopathic agent allowing smokers to quit smoking

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003712A1 (en) * 1991-08-20 1993-03-04 Daniel Mcnair A device for the administration of homeopathic compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501726A (en) * 1981-11-12 1985-02-26 Schroeder Ulf Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
JPS63159313A (en) * 1986-12-24 1988-07-02 Olympus Optical Co Ltd Drug for treatment

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2671451A (en) * 1952-06-16 1954-03-09 Stephen J Bolger Remedial pill
DE1467974A1 (en) * 1964-06-08 1969-01-23 Tsukamoto Kenkichi Process for improving the effectiveness of iron preparations and device for carrying out the process
DE1492136A1 (en) * 1965-01-30 1969-09-18 Seuss Dr Med Willy Device for the therapeutic influence of the human body through static electricity
DE1692771A1 (en) * 1968-02-24 1972-01-05 Willy Dr Med Seuss Process for the preparation of internally or externally applicable physiologically active substances and agents manufactured according to them
BE759692A (en) * 1969-12-23 1971-05-17 Soliman Henri MINERAL-VEGETABLE MEDICINE
FR2258839A1 (en) * 1974-01-28 1975-08-22 Sitbon Georges Colloidal therapeutic iron solutions - treatment for cancer, leukaemia, arterial and cardiac disorders, neurological disorders, anti-radiation agents, etc.
SE431214B (en) * 1977-06-02 1984-01-23 Klaus H Mosbach SET TO MAKE MAGNETIC POLYMER PARTICLES BASED ON A PREFERRED BIOLOGY ACTIVE SUBSTANCE
US4357259A (en) * 1977-08-01 1982-11-02 Northwestern University Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
JPS576041A (en) * 1980-02-25 1982-01-12 Kimikiyo Harada Folding formation type metal stud
FR2477022A1 (en) * 1980-03-03 1981-09-04 Flux Yang Ste Civile DEVICE FOR THE LOCALIZED APPLICATION OF A MAGNETIC FIELD ON AN OBJECT, IN PARTICULAR A LIVING BEING
JPS5945378A (en) * 1982-09-09 1984-03-14 Toyobo Co Ltd Self-adhesive material
JPS6032716A (en) * 1983-07-29 1985-02-19 Yasuo Sawada Antibacterial drug containing specific fatty acid and magnetic iron oxide powder, and prepartion of drug accelerating restoration of patient
JPS61115015A (en) * 1984-11-08 1986-06-02 Shimazaki Shiyubiyou Kk Magnetized cosmetic
EP0208362A1 (en) * 1985-06-28 1987-01-14 The Procter & Gamble Company Dietary supplements containing iron and enterically coated calcium
JPS62175419A (en) * 1986-01-25 1987-08-01 Tomoji Tanaka Artificial hot spring bath agent
DE3634121A1 (en) * 1986-05-09 1987-11-12 Otto Kausch Method and device for improving the effects of liquid or pasty products

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501726A (en) * 1981-11-12 1985-02-26 Schroeder Ulf Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
JPS63159313A (en) * 1986-12-24 1988-07-02 Olympus Optical Co Ltd Drug for treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0409893A4 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0469661A1 (en) * 1990-08-01 1992-02-05 Enza Ciccolo Method for the indentification of frequency and bioenergetic activities in waters and their use
FR2675385A1 (en) * 1991-04-18 1992-10-23 Boulay Maurice Tranquillising and revitalising product containing powdered magnetite
WO1997001355A1 (en) * 1995-06-26 1997-01-16 Antonio Sacchetti Magnetic or electromagnetically induced energization of natural substances
WO2002066041A1 (en) * 2001-02-23 2002-08-29 Herbal Detox Therapy Aps Natural composition
US6552035B2 (en) * 2001-09-13 2003-04-22 Hwa-Mok Park Composition for inducing smoking cessation comprising alkaloids from Radix ipecauanhae
US6844014B1 (en) 2002-07-22 2005-01-18 Stephen Rafkin Herbal healing lotion for veterinary use
EP3166620A1 (en) * 2014-07-11 2017-05-17 Marianna Gross Homeopathic agent allowing smokers to quit smoking
CN106714815A (en) * 2014-07-11 2017-05-24 M·格罗斯 Homeopathy preparation for promoting smoker to stop smoking

Also Published As

Publication number Publication date
IN169075B (en) 1991-08-31
EP0409893A1 (en) 1991-01-30
CA1334936C (en) 1995-03-28
JPH03503648A (en) 1991-08-15
NZ228593A (en) 1992-07-28
AU3426089A (en) 1989-10-16
AU632481B2 (en) 1993-01-07
EP0409893A4 (en) 1991-03-13

Similar Documents

Publication Publication Date Title
US5162037A (en) Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
CN100363022C (en) Pharmaceutical composition with immunoregulation function and method for preparing the same
TWI352597B (en) Composition having effect of moxibustion and press
AU723812B2 (en) Medicinal preparation and a method of medicinal action on human organism
US4352796A (en) Pharmaceutically active plant extract and composition thereof
WO2009051628A2 (en) Transdermal treatment device and method
CN101417013A (en) Traditional Chinese medicine cataplasm for treating rheumatism and ostalgia and preparation method thereof
EP1162988A1 (en) Wafer delivery system
AU632481B2 (en) Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
US5603935A (en) Composition for the treatment of snoring and methods of use thereof
CN103495042A (en) Traditional Chinese medicine composition for treating migraine
CN102302559B (en) Medicament for treating respiratory system diseases and application thereof
RU2346696C2 (en) Method of human immune system stimulation using activated platinoids-containing mineral, method of mineral activation and composition with immune system stimulation properties
CN102552440B (en) Anti-asthmatic and anti-inflammatory medicament and preparation method and application thereof
CN102266408B (en) Use of gardenia extract and borneol effective ingredients in Chinese medicine preparation for intervening in cutaneous prutitus
CN104623376A (en) Medicament for treating prosopalgia
CN101181602B (en) Chinese medicine preparation, preparation method thereof as well as application in the preparation of antiviral and antibacterial drugs
CN101361868A (en) Traditional Chinese medicine combination for treating rheumatism
WO2002094297A1 (en) Herbal composition for the treatment of drug addiction and insomnia
CN1080563C (en) Series medicinal preparation for treating cancer and production method thereof
CN1092976C (en) Application of endive in preparing medicine for treating tuberculosis
CN1050759C (en) Medicinal composite for hysteromyoma and preparing method
AU2002254806B2 (en) Herbal composition for the treatment of drug addiction and insomnia
CN1116106A (en) Jieyinjing medicine for female external genitals
CN103599185A (en) Traditional Chinese medicine composition for treating headache

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR DK FI HU JP LK NO SU

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BF BJ CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1989904967

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1989904967

Country of ref document: EP